Marinus Pharmaceuticals Cash from Investing (TTM) Insights

Marinus Pharmaceuticals Inc (MRNS)

1.41 -0.01 (-0.70%) USD | NASDAQ | Apr 26, 16:00

1.41 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	-28.60M
September 30, 2023	-34.99M
June 30, 2023	59.20M
March 31, 2023	53.86M
December 31, 2022	105.77M
September 30, 2022	104.97M
June 30, 2022	-2.014M
March 31, 2022	-2.543M
December 31, 2021	-1.415M
September 30, 2021	1.788M
June 30, 2021	5.642M
March 31, 2021	7.001M
December 31, 2020	-0.738M
September 30, 2020	-1.256M
June 30, 2020	-4.493M
March 31, 2020	-7.684M
December 31, 2019	3.881M
September 30, 2019	16.84M
June 30, 2019	22.10M
March 31, 2019	24.79M
December 31, 2018	19.92M

Date	Value
September 30, 2018	5.232M
June 30, 2018	-24.46M
March 31, 2018	-23.04M
December 31, 2017	-21.42M
September 30, 2017	-21.41M
June 30, 2017	4.536M
March 31, 2017	1.818M
December 31, 2016	1.396M
September 30, 2016	1.649M
June 30, 2016	-4.576M
March 31, 2016	-3.633M
December 31, 2015	-6.314M
September 30, 2015	-6.848M
June 30, 2015	-1.876M
March 31, 2015	-1.524M
December 31, 2014	-0.033M
September 30, 2014	-0.0031M
June 30, 2014	-0.0051M
March 31, 2014	-0.0131M
December 31, 2013	-0.0171M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-34.99M

Minimum

Sep 2023

105.77M

Maximum

Dec 2022

15.65M

Average

1.788M

Median

Sep 2021

Cash from Investing (TTM) Benchmarks